RUCHIRA PAPERS LTD
看多
已更新

Ruchira Papers - Investment stock (can rebound)

222
Scrip can rebound back as it is facing resistance at support levels with double bottom and is already trading around 52-week low

Rest in charts.

Bullish momentum sign
1) RSI indicator rising in past few sessions
2) Although, Broadening Falling wedge pattern in play which is bearish sign however scrip has started to face resistance after partial decline
3) Stake holding of known investors like Dolly Khanna
moneycontrol.com/news/business/companies/hsil-awaiting-regulatory-approvals-for-demerger-2535875.html
4) Fundamentally sound company which has shown great results with progressive rise in PAT YoY basis, reducing debts with RoE more than 20%, CAGR coming in 15.87%
business-standard.com/article/news-cm/meghmani-organics-consolidated-net-profit-rises-130-95-in-the-december-2017-quarter-118021000690_1.html
indiainfoline.com/article/editorial-interviews-leader-speak/interview-jatinder-singh-chairman-whole-time-director-ruchira-papers-limited-117062900237_1.html
screener.in/company/RUCHIRA/

Aiming towards TP- resistance zone and beyond thereon after entry confirmation until the scrip sustains above support levels.

SL as per risk appetite

screener.in/company/RUCHIRA/
註釋
Bullish pin bar in play in today's session. Gap up might be seen tomorrow as MACD also showing bullish crossover

快照
註釋
After recent pullback from ascending broadening wedge, The scrip can be seen in Bullish Divergence forming lower bottom and higher bottom in MACD and RSI. Retracement thereon with bullish reversal might take back the scrip towards 52-week highs

快照
交易進行
交易進行
快照
交易進行
Cup and candle pattern -> Bullish Engulfing -> pullback -> Bullish Engulfing
快照
Will the scrip manage to break the resistance and surge this time owing to good fundamentals and strong apprehension given by top management of the company after the company successfully completed implementation of modernization programme for which topline and bottomline will grow in Q2Fy19

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。